Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments for:

Mitochondria: pharmacological manipulation of cell death
Lisa Bouchier-Hayes, … , Lydia Lartigue, Donald D. Newmeyer
Lisa Bouchier-Hayes, … , Lydia Lartigue, Donald D. Newmeyer
Published October 3, 2005
Citation Information: J Clin Invest. 2005;115(10):2640-2647. https://doi.org/10.1172/JCI26274.
View: Text | PDF
Review Series

Mitochondria: pharmacological manipulation of cell death

  • Text
  • PDF
Abstract

Cell death by apoptosis or necrosis is often important in the etiology and treatment of disease. Since mitochondria play important roles in cell death pathways, these organelles are potentially prime targets for therapeutic intervention. Here we discuss the mechanisms through which mitochondria participate in the cell death process and also survey some of the pharmacological approaches that target mitochondria in various ways.

Authors

Lisa Bouchier-Hayes, Lydia Lartigue, Donald D. Newmeyer

×

Mitochondria and apoptosis

Submitter: Heikki Savolainen | heikki.savolainen@stm.fi

Dept. of Occup.Safety & Hlth., Tampere, Finland

Published October 5, 2005

This timely and thought-provoking review opens up new vistas for clinicians and research people. It is also very pertinent to occupational toxicology. As an example, I would like to cite the fact that toxic metabolites from alkoxyethyl ethers, the corresponding alkokyacetic acids, inhibit the succinate dehydrogenase at complex II in mitochondria (1). The enzyme links the tricarboxylic acid cycle to the respiratory chain. The inhibition activates the caspase pathway (2), and it seems that the accumulating succinate also inhibits HIF-alpha proline hydroxylation resulting in the activation of hypoxia responsive elements. Thus, the mitochondrial effects are also critical to modern toxicology.
1. Liesivuori et al. Arch Toxicol 73: 229 (1999) 2. Dathe et al. Hautarzt 56: 768 (2005)

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts